In osteoporosis, bones become brittle and fragile, putting them at high risk of fractures or breaks. These “fragility fractures” can cause pain, suffering, disability and even death, and patients have increased risks of repeat fractures.
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 27.01.2025 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed